| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/30/2003 | WO2003008612A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced rsea or rsec gene |
| 01/30/2003 | WO2003008611A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced talb gene |
| 01/30/2003 | WO2003008610A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced pfkb gene |
| 01/30/2003 | WO2003008609A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced pykf gene |
| 01/30/2003 | WO2003008608A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced phoe gene |
| 01/30/2003 | WO2003008607A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/30/2003 | WO2003008606A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced phob or phor gene |
| 01/30/2003 | WO2003008605A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced male gene |
| 01/30/2003 | WO2003008604A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated aceb gene |
| 01/30/2003 | WO2003008603A2 Process for the preparation of l-amino acids using strains of the enterobacteri acea family which contain an attenuated aspa gene |
| 01/30/2003 | WO2003008602A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated ugpb gene |
| 01/30/2003 | WO2003008600A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 01/30/2003 | WO2003008593A2 A thermostable isomerase and use thereof in particular for producing tagatose |
| 01/30/2003 | WO2003008590A1 Human mitochondrial gpat |
| 01/30/2003 | WO2003008588A2 Method for producing 2-keto-l-gulonic acid and vitamin c while using l-sorbose dehydrogenase and l-sorbosone dehydrogenase |
| 01/30/2003 | WO2003008582A1 Novel human-origin protein binding to sphingosine kinase 1 and polynucleotide encoding the protein |
| 01/30/2003 | WO2003008581A1 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING APOPTOSIS REGULATOR |
| 01/30/2003 | WO2003008579A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 01/30/2003 | WO2003008575A2 Dna sequences for regulating transcription |
| 01/30/2003 | WO2003008574A1 Mutations in ion channels |
| 01/30/2003 | WO2003008568A2 Culture medium for cultivation of filamentous fungi |
| 01/30/2003 | WO2003008565A1 Recovery of bioleaching microbes |
| 01/30/2003 | WO2003008560A2 A novel g protein-coupled receptor, gave8 |
| 01/30/2003 | WO2003008548A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 01/30/2003 | WO2003008546A2 Biogenic fpa: enzymatic production of formylphosphonic acid by the oxidation of hydroxymethylphosphonic acid |
| 01/30/2003 | WO2003008540A2 Abiotic stress responsive polynucleotides and polypeptides |
| 01/30/2003 | WO2003008537A2 Epitope sequences |
| 01/30/2003 | WO2003008534A2 Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof |
| 01/30/2003 | WO2003008455A1 Activity monitor molecules for g-protein trimer |
| 01/30/2003 | WO2003008454A2 Glycoprotein vi fusion proteins |
| 01/30/2003 | WO2003008452A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors |
| 01/30/2003 | WO2003008451A2 Modification of human variable domains |
| 01/30/2003 | WO2003008449A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | WO2003008448A2 Novel human proton-gated channels |
| 01/30/2003 | WO2003008446A1 Polypeptides relating to signal transfer of advanced glycation end product receptor |
| 01/30/2003 | WO2003008445A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/30/2003 | WO2003008437A2 Protein and nucleic acid expression systems |
| 01/30/2003 | WO2003008434A2 Strains of bacteria destructive for hydrocarbon-containing compounds, surface-active agents and xenobiotics used for cleaning the hydrosphere |
| 01/30/2003 | WO2003007889A2 Therapeutic agents comprising pro-apoptotic proteins |
| 01/30/2003 | WO2003007880A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | WO2003007800A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | WO2003007699A2 Transcription factors of cereals |
| 01/30/2003 | WO2002077241A3 Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 01/30/2003 | WO2002068585A9 Tip39 polypeptides |
| 01/30/2003 | WO2002048382A3 Method for the production of a heterologous protein by a fungus |
| 01/30/2003 | WO2002048333A3 Novel human kinases and uses thereof |
| 01/30/2003 | WO2002045523A3 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/30/2003 | WO2002034879A3 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 01/30/2003 | WO2002034772A3 Novel compounds |
| 01/30/2003 | WO2002031143A3 Nucleic acid sequences encoding cmg proteins cmg proteins and methods for their use |
| 01/30/2003 | WO2002029035A3 Method to alter sugar moieties |
| 01/30/2003 | WO2002026988A3 Human drug metabolizing enzymes |
| 01/30/2003 | WO2002020763A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/30/2003 | WO2002018567A3 Regulation of human aminotransferase-like enzyme |
| 01/30/2003 | WO2002016567A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | WO2002016550A3 Antisense rna expression strategies effective against streptococcus thermophilus bacteriophage |
| 01/30/2003 | WO2002006322A3 Polycomb genes mez1 and mez2 from maize |
| 01/30/2003 | WO2002004599A3 Placental protein having multiple egf-like domains |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | WO2001090359A3 G-protein coupled receptors |
| 01/30/2003 | WO2001079286A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 01/30/2003 | WO2001068835A3 Method for modifying a nucleic acid |
| 01/30/2003 | WO2001064877A9 Human schizophrenia gene |
| 01/30/2003 | US20030024010 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
| 01/30/2003 | US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
| 01/30/2003 | US20030023074 Galanin receptor GALR3 and nucleotides encoding same |
| 01/30/2003 | US20030023073 Growth differentiation factor-15 |
| 01/30/2003 | US20030023070 For diagnosis, prophylaxis and therapy; therapy of cancer |
| 01/30/2003 | US20030023061 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 01/30/2003 | US20030023057 Used in assaying for cancer, such as melanoma |
| 01/30/2003 | US20030023056 In immunogenic preparations or diagnostic applications |
| 01/30/2003 | US20030022860 CD40 binding molecules and CTL peptides for treating tumors |
| 01/30/2003 | US20030022849 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/30/2003 | US20030022841 Growth differentiation factor, Lefty-1 |
| 01/30/2003 | US20030022822 Novel compounds |
| 01/30/2003 | US20030022821 A modified lactoferrin peptide which is cytotoxic, 7 to 25 amino acids in length, with three or more cationic residues and has one or more extra bulky and lipophilic amino acids as compared to the native lactoferrin seuquence |
| 01/30/2003 | US20030022373 Generation of preferential expression vectors; obtain nucleotide sequences, digest, incubate with insertion sequences, ligate, recover vector |
| 01/30/2003 | US20030022360 Biofilter equipped with a stirrer and injector of solid feed and method for removing odor and volatile organic compounds from waste gases suing the same |
| 01/30/2003 | US20030022359 Transgenic algae for delivering antigens to an animal |
| 01/30/2003 | US20030022355 Vectors and methods for gene transfer |
| 01/30/2003 | US20030022354 Protein c derivatives |
| 01/30/2003 | US20030022351 Alkaline proteases |
| 01/30/2003 | US20030022349 Virulence-associated nucleic acid sequences and uses thereof |
| 01/30/2003 | US20030022348 Modified forms of pullulanase |
| 01/30/2003 | US20030022347 Bacterial galactanases and use thereof |
| 01/30/2003 | US20030022346 Enzymatic polypeptide for use in detergents, textile processing and papermaking |
| 01/30/2003 | US20030022341 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 01/30/2003 | US20030022339 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | US20030022338 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 01/30/2003 | US20030022336 Enzymatic polypeptide for use in the diagnosis of diabetes |
| 01/30/2003 | US20030022333 Preservation of samples by dehydration; obtain sample, dry, cool and store on shell |
| 01/30/2003 | US20030022332 Polypeptide or use in the treatment prevention and diagnosis of cancer, viral, inflammatory and autoimmune diseqases |
| 01/30/2003 | US20030022325 Nucleotide sequences coding transport protein for use in diagnosis and treatment of cancers, kidney, bone and nervous sysem disorders |
| 01/30/2003 | US20030022323 Generation of 1,3-propanediol; obtain microorganism, transform with vector, propagate in nutrient broth, express vector, recover propanediol |
| 01/30/2003 | US20030022321 Novel compounds |
| 01/30/2003 | US20030022320 Nucleic acid sequences coding polypeptide for use in the generation of preferential amino acids, for use in animal nutrients, pharmocology and medicines |
| 01/30/2003 | US20030022312 Human hepatoma-derived growth factor-2 |
| 01/30/2003 | US20030022308 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 01/30/2003 | US20030022306 Polypeptide for use in the treatment of cancer |
| 01/30/2003 | US20030022288 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |